Metabolic syndrome in newly diagnosed type 2 diabetes mellitus using NCEP-ATP III, the Nnewi experience

Nigerian Journal of Clinical Practice

Volumn 15, Issue 4, 2012, Pages 475-480

  Osuji, C U ^a   Nzerem, B A ^b   Dioka, C E ^a   Onwubuya, E I ^a  

^a NNAMDI AZIKIWE UNIVERSITY   (Nigeria)

^b Chapel Group Hospital   (Nigeria)

Author keywords

Blood sugar; Metabolic syndrome; Newly diagnosed type 2 diabetes; Prevalence

Indexed keywords

ADULT; AGED; ARTICLE; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NIGERIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; RISK FACTOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NIGERIA; PREVALENCE; RISK FACTORS; YOUNG ADULT;

EID: 84871659404     PISSN: 11193077     EISSN: None     Source Type: Journal    
DOI: 10.4103/1119-3077.104530     Document Type: Article

References (40)

1. Kylin E. Studien uber das. Hypertonie-Hyperglyka "mie Hyperurika" amiesyndrom. Zentrablatt fuer Innere Medizin 1923;44:105-27.
2. Alberti KG, Zimmet P, Shaw J. IDF Epidemiology Task Force Consensus Group. The metabolic syndrome a new worldwide definition. Lancet 2005;366:1059-62. (Pubitemid 41338752)
3. US Census Bureau, Population Estimates, 2004. Available from: http://www.wrongdiagnosis.com/m/metabolic-syndrome/stats-country.htm. [Last Accessed 2010 Oct. 5].
4. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: Report of a WHO Consultation. Part 1: Diagnosis and classification of diabetes mellitus. Geneva, Switzerland: World Health Organization; 1999. Available from: http://whqlibdoc.who.int/hq/1999WHO- NCD-NCS-99.2.pdf. [Last Accessed 2010 Oct. 5].
5. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults: Executive Summary of the Third Report of the National Cholesterol Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
6. Balkau B, Charles MA. Comment on the provisional report from THE WHO CONSULTATION. European Group for the study of Insulin Resistance (EGIR). Diabet Med 1999;16:442-3.
7. Zimmet P, Alberti G, Shaw J. A new IDF worldwide definition of the metabolic syndrome: The rationale and the results. Diabetes Voice 2005;50:31-3.
8. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Bonadonna RC, et al. Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: Prospective data from the Bruneck study. Diabetes Care 2003;26:1251-7. (Pubitemid 36929281)
9. Ecke RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005;365:1415-28. (Pubitemid 40523737)
10. King H, Aubert RE, Herman WH. Global Burden of diabetes 1995-2025: Prevalence, numerical and projections. Diabetes Care 1998;21:1414-31. (Pubitemid 28405191)
11. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010;87:4-14.
12. Krause MP, Hallage T, Goma M P R, Goss FL, Robertson R, Da Silva SA. Association of Adiposity, Cardiorespiratory, Fitness and Exercise, Practice with prevalence of type 2 diabetes in Brazilian Elderly women. Int J Med Sci 2007;4:288-92. (Pubitemid 350277524)
13. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, et al. Prevalence of Obesity, diabetes, and obesity related health risk factors, 2001. JAMA 2003;289:76-9. (Pubitemid 36026281)
14. UK Prospective Diabetes Study Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.
15. Holman RR, Paul SK, Bethel MA, Mathews DR, Neil HA. 10-year Follow-up of Intensive Intensive Glucose Control in Type 2 Diabetes. N Engl J Med 2008;359:1577-89.
16. The ADVANCE Collaborative Group. Intensive Blood Glucose Control in Type 2 Diabetes. N Engl J Med 2008;358:2560-72.
17. Ford ES, Giles WH, Dietz WH. Prevalence of Metabolic Syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey. JAMA 2002;287:356-9. (Pubitemid 34251969)
18. Balkau B, Charles MA, Drivsholm T, Borch-Johnsen K, Wareham N, Yudkin JS, et al. Frequency of WHO-defined metabolic syndrome in European cohort and an alternative definition of an insulin resistance syndrome. Diabetes Metab 2002;28:364-76. (Pubitemid 35434310)
19. Surana SP, Shah DB, Gala K, Hoskote SS, Gill N, Joshi SR et al. Prevalence of Metabolic Syndrome in an Indian Population using the NCEP ATP III. J Assoc Physicians India 2008;56:865-8.
20. Vega GL. Obesity, the metabolic syndrome, and cardiovascular disease. Am Heart J 2001;142:1108-16. (Pubitemid 33131824)
21. Liu S, Manson JE. Dietary carbohydrates, physical inactivity, obesity, and the 'metabolic syndrome' as predictors of coronary heart disease. Curr Opin Lipidol 2001;12:395-404. (Pubitemid 32675500)
22. Malik S, Wong ND, Franklin SS. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004;110:1245-50. (Pubitemid 39202340)
23. Meigs JB, Larson MG, D'Agostino RB. Coronary artery calcification in type 2 diabetes and insulin resistance: The Framingham Offspring Study. Diabetes Care 2002;25:1313-19. (Pubitemid 41071138)
24. Reilly MP, Wolfe ML, Rhodes T. Measures of insulin resistance add incremental value to the clinical diagnosis of metabolic syndrome in association with coronary atherosclerosis. Circulation 2004;110:803-9. (Pubitemid 39096007)
25. Alebiosu CO, Odusan BO. Metabolic syndrome in subjects with type 2 diabetes mellitus. J Natl Med Assoc 2004;96:817-21. (Pubitemid 38745790)
26. Isezuo SA. Is high density lipoprotein cholesterol useful in diagnosis of metabolic syndrome in native Africans with type 2 diabetes? Ethn Dis 2005;15:6-10. (Pubitemid 40310048)
27. Abdul-Rahim HF, Husseini A, Bjertness E, Giacaman R, Gordon NH, Jervell J. The metabolic syndrome in the West Bank population: An urban-rural comparison. Diabetes Care 2001;24:275-9. (Pubitemid 32119124)
28. Akbar DH. Metabolic syndrome is common in Saudi types 2 diabetic patients. Diabetes Int 2002;12:47-9.
29. Mansour AA. The prevalence of metabolic syndrome among patients with type 2 diabetes mellitus in Basrah. Middle East Journal Family Medicine 2007;5:20-2.
30. Park HS, Oh SW, Cho S, Choi WH, Kim YS. The metabolic syndrome and associated lifestyle factor among South Korean adults. Int J Epidemiol 2004;33:328-36. (Pubitemid 38578831)
31. Isezuo SA, Ezunu E. Demographic and clinical correlates of metabolic syndrome in Native African type-2 diabetic patients. J Natl Med Assoc 2005;97:557-63. (Pubitemid 40463586)
32. Chuang SY, Chen CH, Tsai ST, Chou P. Clinical identification of the metabolic syndrome in Kinmen. Acta Cardiol Sin 2002;18:16-23. (Pubitemid 34650765)
33. Azizi F, Salehi P, Etemadi A, Zahedi-Asl S. Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. Diabetes Res Clin Pract 2003;61:29-37. (Pubitemid 36808841)
34. Gupta A, Gupta R, Sarna M, Rastogi S, Gupta VP, Kothari K. Prevalence of diabetes, impaired fasting glucose and insulin resistance syndrome in an urban Indian population. Diabetes Res Clin Pract 2003;61:69-76. (Pubitemid 36808845)
35. Park JS, Park HD, Yun JW, Jung CH, Lee WY, Kim SW. Prevalence of the metabolic syndrome as defined by NCEP-ATP III among the urban Korean population. Korean J Med 2002;63:290-8.
36. Chung HS, Seo JA, Kim SG, Kim NH, Kim DM, Chung CH et al. Relationship Between Metabolic Syndrome and Risk of Chronic Complications in Koreans with Type 2 Diabetes. Korean Diabetes J 2009;33:392-400.
37. Thomas GN, Ho SY, Janus ED, Lam KS, Hedley AJ, Lam TH. The US National Cholesterol Education Programme Adult Treatment Panel (NCEP ATP III) prevalence of the metabolic syndrome in a Chinese population. Diabetes Res Clin Pract 2005;67:251-7. (Pubitemid 40254315)
38. Boden G, Chen X, De Santis RA, Kendrick Z. Effects of age and body fat on insulin resistance in healthy men. Diabetes Care 1993;16:728-33. (Pubitemid 23127178)
39. Ogbera AO. Prevalence and gender distribution of the metabolic syndrome. Diabetol Metab Syndr 2010;2:1-3.
40. Wokoma FS. Diabetes and hypertension in Africa - an overview. Diabetes Int 2002;12:36-40.